Works by Vall-Llovera, Ferran

Results: 25

A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.

Published in:

Cancer Medicine, 2020, v. 9, n. 7, p. 2317, doi. 10.1002/cam4.2814

By:

Ribera, Josep‐Maria;
Morgades, Mireia;
Montesinos, Pau;
Tormo, Mar;
Martínez‐Carballeira, Daniel;
González‐Campos, José;
Gil, Cristina;
Barba, Pere;
García‐Boyero, Raimundo;
Coll, Rosa;
Pedreño, María;
Ribera, Jordi;
Mercadal, Santiago;
Vives, Susana;
Novo, Andrés;
Genescà, Eulàlia;
Hernández‐Rivas, Jesús‐María;
Bergua, Juan;
Amigo, María‐Luz;
Vall‐Llovera, Ferran

Publication type:

Article

Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1

By:

Oñate, Guadalupe;
Pratcorona, Marta;
Garrido, Ana;
Artigas-Baleri, Alicia;
Bataller, Alex;
Tormo, Mar;
Arnan, Montserrat;
Vives, Susana;
Coll, Rosa;
Salamero, Olga;
Vall-Llovera, Ferran;
Sampol, Antònia;
Garcia, Antoni;
Cervera, Marta;
Avila, Sara Garcia;
Bargay, Joan;
Ortín, Xavier;
Nomdedéu, Josep F.;
Esteve, Jordi;
Sierra, Jorge

Publication type:

Article

Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1

By:

Oñate, Guadalupe;
Pratcorona, Marta;
Garrido, Ana;
Artigas-Baleri, Alicia;
Bataller, Alex;
Tormo, Mar;
Arnan, Montserrat;
Vives, Susana;
Coll, Rosa;
Salamero, Olga;
Vall-Llovera, Ferran;
Sampol, Antònia;
Garcia, Antoni;
Cervera, Marta;
Avila, Sara Garcia;
Bargay, Joan;
Ortín, Xavier;
Nomdedéu, Josep F.;
Esteve, Jordi;
Sierra, Jorge

Publication type:

Article

Genetic evolution and relapse‐associated mutations in adult T‐cell acute lymphoblastic leukemia patients treated in PETHEMA trials.

Published in:

HemaSphere, 2025, v. 9, n. 5, p. 1, doi. 10.1002/hem3.70148

By:

González‐Gil, Celia;
Lopes, Thaysa;
Morgades, Mireia;
Fuster‐Tormo, Francisco;
Montesinos, Pau;
Medina, Carlos Rodríguez;
Hermosín, Lourdes;
González‐Martínez, Teresa;
Queipo, María‐Paz;
González‐Campos, José;
Martínez‐Sánchez, Pilar;
Díaz‐Beya, Marina;
Coll, Rosa;
Maluquer, Clara;
Zamora, Lurdes;
Artola, Teresa;
Vall‐Llovera, Ferran;
Tormo, Mar;
Torrent, Anna;
Martínez‐Laperche, Carolina

Publication type:

Article

P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3‐ITD MUTATED AML.

Published in:

HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969032.40255.74

By:

Tormo, Mar;
Diaz‐Beya, Marina;
Beneit, Paola;
Fernández Moreno, Ainhoa;
Arnan, Montserrat;
Garrido Diaz, Ana;
Vives, Susana;
García Fortes, Maria;
Sampol, Antonia;
Labrador, Jorge;
Garcia‐Guiñon, Antonio;
Botella, Carmen;
Miguel Bergua Burgues, Juan;
Olave, Mayte;
Luz Amigo, Maria;
Ortín, Xavier;
Ferran Vall‐Llovera, Ferrand;
Pereiro, Maria;
Serrano, Josefina;
Jose Sayas Lloris, Maria

Publication type:

Article

P1147: FEASIBILITY AND OUTCOME AFTER DOSE REDUCTION OF IMMUNOCHEMOTHERAPY IN YOUNG ADULTS WITH BURKITT LYMPHOMA AND LEUKEMIA. RESULTS OF THE BURKIMAB14 TRIAL.

Published in:

2023

By:

Maria Ribera, Josep;
Morgades, Mireia;
García-Calduch, Olga;
Sirvent, Maialen;
Buendía Ureña, Buenaventura;
Cervera, Marta;
Luzardo, Hugo;
Hernández Rivas, Jesus;
Sitges Arriaga, Marta;
Garcia Cadenas, Irene;
Abrisquet Acosta, Pablo;
Montesinos, Pau;
Bastos Oreiro, Mariana;
Queipo de Llano, María-Paz;
Bravo, Pilar;
Torrent, Anna;
Puente, Maria Pilar Herrera;
Garcia-Guiñon, Antonio;
Vall-Llovera Calmet, Ferran;
Serrano, Josefina

Publication type:

Abstract

S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB.

Published in:

2023

By:

Miguel Bergua Burgues, Juan;
Rodríguez-Veiga, Rebeca;
Cano Ferri, Isabel;
Vall-Llovera Calmet, Ferran;
Garcia-Guiñon, Antonio;
Gomez Espuch, Joaquin;
Colorado, Mercedes;
Casas-Avilés, Ignacio;
Esteve, Jordi;
Sampol, Antonia;
Victoria Verdugo, Maria;
Ramos, Fernando;
Valero, Marta;
Gloria Acuña Cruz, Evelyn;
Boluda, Blanca;
Torres Miñana, Laura;
Martinez-Lopez, Joaquín;
Barragan, Eva;
Ayala Diaz, Rosa;
Martinez-Cuadrón, David

Publication type:

Abstract

Validation of the Burkitt Lymphoma International Prognostic Index in patients treated with two prospective chemoimmunotherapy trials in Spain.

Published in:

2022

By:

Ribera, Josep-Maria;
García, Olga;
Buendía-Ureña, Buenaventura;
Terol, Maria-José;
Vicent, Ana;
Vall-Llovera, Ferran;
Bergua, Juan;
García-Cadenas, Irene;
Esteve, Jordi;
Ribera, Jordi;
Acuña-Cruz, Evelyn;
Herrera, Pilar;
Hernández-Rivas, Jesus-Maria;
Abrisqueta, Pau;
González-Campos, José;
Rodríguez, Carlos;
Bastos-Oreiro, Mariana;
Genescà, Eulàlia;
Caminos, Nerea;
Queipo de Llano, Maria-Paz

Publication type:

Letter

Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma.

Published in:

2019

By:

Baptista, Maria Joao;
Tapia, Gustavo;
Morgades, Mireia;
Muncunill, Josep;
Muñoz-Marmol, Ana-María;
Montoto, Silvia;
Gribben, John G.;
Calaminici, Maria;
Martinez, Antonio;
Gonzalez-Farre, Blanca;
Dlouhy, Ivan;
González-Barca, Eva;
Terol, María-José;
Miralles, Pilar;
Alcoceba, Miguel;
Vall-Llovera, Ferran;
Briones, Javier;
Abrisqueta, Pau;
Abella, Eugenia;
Provencio, Mariano

Publication type:

Letter

Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia.

Published in:

Leukemia & Lymphoma, 2018, v. 59, n. 7, p. 1634, doi. 10.1080/10428194.2017.1397661

By:

Ribera, Josep-Maria;
Morgades, Mireia;
Montesinos, Pau;
Martino, Rodrigo;
Barba, Pere;
Soria, Beatriz;
Bermúdez, Arancha;
Moreno, María-José;
González-Campos, José;
Vives, Susana;
Gil, Cristina;
Abella, Eugenia;
Guàrdia, Ramon;
Martínez-Carballeira, Daniel;
Martínez-Sánchez, Pilar;
Amigo, María-Luz;
Mercadal, Santiago;
Serrano, Alfons;
López-Martínez, Aurelio;
Vall-Llovera, Ferran

Publication type:

Article

Bilateral phrenic nerve palsy induced by subcutaneous bortezomib in a patient with newly diagnosed multiple myeloma: first case reported.

Published in:

Leukemia & Lymphoma, 2017, v. 58, n. 2, p. 482, doi. 10.1080/10428194.2016.1195496

By:

López, Meritxell;
Martínez Lacasa, Xavier;
Martí, Josep M.;
Muntañola, Ana;
Fernández, Mar;
Huertas, Sonia;
Saumell, Sílvia;
De Diego, Isabel;
Bustamante, Gabriela;
Mesa, Alba;
Canet, Marta;
Julià, Marta;
Vall-Llovera, Ferran

Publication type:

Article

Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients.

Published in:

Leukemia & Lymphoma, 2014, v. 55, n. 10, p. 2341, doi. 10.3109/10428194.2013.878933

By:

Xicoy, Blanca;
Ribera, Josep-Maria;
Müller, Markus;
García, Olga;
Hoffmann, Christian;
Oriol, Albert;
Hentrich, Marcus;
Grande, Carlos;
Wasmuth, Jan-Christian;
Esteve, Jordi;
van Lunzen, Jan;
del Potro, Eloy;
Knechten, Heribert;
Brunet, Salut;
Mayr, Christoph;
Escoda, Lourdes;
Schommers, Philipp;
Alonso, Natalia;
Vall-llovera, Ferran;
Pérez, Montserrat

Publication type:

Article

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1706, doi. 10.3109/10428194.2012.752080

By:

Altés, Albert;
Par, Laia;
Esquirol, Albert;
Xicoy, Blanca;
Rámila, Elena;
Vicente, Laura;
López, Rosario;
Orriols, Jaume;
Vall-llovera, Ferran;
Sánchez-González, Blanca;
del Río, Elisabeth;
Sureda, Anna;
Páez, David;
Baiget, Montserrat

Publication type:

Article

Pharmacogenetic analysis in the treatment of Hodgkin lymphoma.

Published in:

Leukemia & Lymphoma, 2013, v. 54, n. 2, p. 1, doi. 10.3109/10428194.2012.752080

By:

Altés, Albert;
Paré, Laia;
Esquirol, Albert;
Xicoy, Blanca;
Rámila, Elena;
Vicente, Laura;
López, Rosario;
Orriols, Jaume;
Vall-llovera, Ferran;
Sánchez-González, Blancalez;
del Río, Elisabeth;
Sureda, Anna;
Páez, David;
Baiget, Montserrat

Publication type:

Article

Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.

Published in:

Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910

By:

Ribera, Josep‐Maria;
Morgades, Mireia;
Genescà, Eulàlia;
Chapchap, Eduardo‐Cerello;
Montesinos, Pau;
Acuña‐Cruz, Evelyn;
Gil, Cristina;
García‐Cadenas, Irene;
Barba, Pere;
González‐Campos, José;
Queipo de Llano, María‐Paz;
Torrent, Anna;
Ribera, Jordi;
Granada, Isabel;
Bernal, Teresa;
Díaz‐Beyá, Marina;
Amigo, María‐Luz;
Coll, Rosa;
Tormo, Mar;
Vall‐llovera, Ferran

Publication type:

Article

Correction to: An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.

Published in:

2018

By:

Steegmann, Juan Luis;
Colomer, Dolors;
Gómez-Casares, Maria-Teresa;
García-Gutiérrez, Valentín;
Ortí, Guillermo;
Ramírez-Payer, Angel;
Olavarria, Eduardo;
Vall-llovera, Ferrán;
Giraldo, Pilar;
Conde, Eulogio;
Vallansot, Rolando;
López-Lorenzo, Jose Luis;
Palomera, Luis;
Álvarez-Larrán, Alberto;
Conesa, Venancio;
Bautista, Guiomar;
Casas, Laura;
Giles, Frank;
Hochhaus, Andreas;
Casado-Montero, Luis Felipe

Publication type:

Erratum

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase.

Published in:

Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 10, p. 2059, doi. 10.1007/s00432-017-2445-z

By:

Steegmann, Juan;
Colomer, Dolors;
Gómez-Casares, Maria-Teresa;
García-Gutiérrez, Valentín;
Ortí, Guillermo;
Ramírez-Payer, Angel;
Olavarria, Eduardo;
Vall-llovera, Ferrán;
Giraldo, Pilar;
Conde, Eulogio;
Vallansot, Rolando;
López-Lorenzo, Jose;
Palomera, Luis;
Álvarez-Larrán, Alberto;
Conesa, Venancio;
Bautista, Guiomar;
Casas, Laura;
Giles, Frank;
Hochhaus, Andreas;
Casado-Montero, Luis

Publication type:

Article

Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?

Published in:

Annals of Hematology, 2018, v. 97, n. 11, p. 2089, doi. 10.1007/s00277-018-3413-7

By:

Osorio, Santiago;
Escudero-Vilaplana, Vicente;
Gómez-Centurión, Ignacio;
Pérez-López, Raúl;
Ayala, Rosa;
Vall-Llovera, Ferrán;
García-Gutierrez, Valentín;
Gómez Casares, María Teresa;
González San Miguel, José David;
Hernández-Rivas, José-Ángel;
Sánchez-Guijo, Fermín;
Martínez-García, Ana Belén;
Villalón, Lucia;
Conesa-García, Venancio;
Rodriguez, Alicia;
Casado, Felipe;
Garcia-Gonzalez, Xandra;
Sáez Perdomo, María Nieves;
Baños, Úrsula;
Steegmann, Juan Luis

Publication type:

Article

Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)

Published in:

2013

By:

Ribera, Josep-Maria;
García, Olga;
Grande, Carlos;
Esteve, Jordi;
Oriol, Albert;
Bergua, Juan;
González-Campos, José;
Vall-Llovera, Ferran;
Tormo, Mar;
Hernández-Rivas, Jesús-Maria;
García, Daniel;
Brunet, Salut;
Alonso, Natalia;
Barba, Pere;
Miralles, Pilar;
Llorente, Andreu;
Montesinos, Pau;
Moreno, Maria-José;
Hernández-Rivas, Jose-Angel;
Bernal, Teresa

Publication type:

Journal Article

Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status.

Published in:

Cancer (0008543X), 2013, v. 119, n. 9, p. 1660, doi. 10.1002/cncr.27918

By:

Ribera, Josep‐Maria;
García, Olga;
Grande, Carlos;
Esteve, Jordi;
Oriol, Albert;
Bergua, Juan;
González‐Campos, José;
Vall‐llovera, Ferran;
Tormo, Mar;
Hernández‐Rivas, Jesús‐Maria;
García, Daniel;
Brunet, Salut;
Alonso, Natalia;
Barba, Pere;
Miralles, Pilar;
Llorente, Andreu;
Montesinos, Pau;
Moreno, Maria‐José;
Hernández‐Rivas, Jose‐Ángel;
Bernal, Teresa

Publication type:

Article

Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.

Published in:

British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857

By:

Bataller, Alex;
Oñate, Guadalupe;
Diaz‐Beyá, Marina;
Guijarro, Francesca;
Garrido, Ana;
Vives, Susana;
Tormo, Mar;
Arnan, Montserrat;
Salamero, Olga;
Sampol, Antònia;
Coll, Rosa;
Vall‐Llovera, Ferran;
Oliver‐Caldés, Aina;
López‐Guerra, Mònica;
Pratcorona, Marta;
Zamora, Lurdes;
Villamon, Eva;
Roué, Gaël;
Blanco, Adoración;
Nomdedeu, Josep F.

Publication type:

Article

Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy.

Published in:

2020

By:

Ribera, Josep-Maria;
García, Olga;
Chapchap, Eduardo Cerello;
Gil, Cristina;
González-Campos, José;
Barba, Pere;
Amigo, María-Luz;
Moreno, María-José;
Lavilla, Esperanza;
Alonso, Natalia;
Bergua, Juan-Miguel;
Tormo, Mar;
Ribera, Jordi;
Sierra, Magdalena;
Martínez-Carballeira, Daniel;
Mercadal, Santiago;
Hernández-Rivas, Jesús-María;
Vall-llovera, Ferran;
Genescà, Eulàlia;
Cladera, Antònia

Publication type:

journal article

Prognostic value of measurable residual disease (MRD) for venetoclax in combination with hypomethylating agents in patients diagnosed with acute myeloid leukemia: validation of the ELN-2021 MRD recommendations.

Published in:

Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01298-6

By:

Jimenez-Vicente, Carlos;
Cardus, Aina;
Castaño-Diez, Sandra;
Ramil, Guillermo;
Garcia-Avila, Sara;
Gomez-Perez, Lucia;
Esteban, Daniel;
Arribas, Iago;
Sturla, Antonella Lucia;
Lopez-Guerra, Monica;
Martinez-Roca, Alexandra;
Cortes-Bullich, Albert;
Perez-Valencia, Amanda Isabel;
Zugasti, Ines;
Monge, Ines;
Carcelero, Esther;
Vall-Llovera, Ferran;
Vives, Susana;
Sierra, Jorge;
Nomdedeu, Josep

Publication type:

Article

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

Published in:

Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5

By:

Oñate, Guadalupe;
Garrido, Ana;
Arnan, Montserrat;
Pomares, Helena;
Alonso, Ester;
Tormo, Mar;
Diaz-Beya, Marina;
Vives, Susana;
Zamora, Lurdes;
Sampol, Antonia;
Coll, Rosa;
Salamero, Olga;
Cervera, Marta;
Garcia, Antoni;
Vall-Llovera, Ferran;
Garcia-Avila, Sara;
Bargay, Joan;
Ortin, Xavier;
Iranzo, Eva;
Guijarro, Francisca

Publication type:

Article

Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials.

Published in:

European Journal of Haematology, 2019, v. 102, n. 1, p. 79, doi. 10.1111/ejh.13178

By:

Barba, Pere;
Morgades, Mireia;
Montesinos, Pau;
Gil, Cristina;
Fox, María‐Laura;
Ciudad, Juana;
Moreno, María‐José;
González‐Campos, José;
Genescà, Eulàlia;
Martínez‐Carballeira, Daniel;
Martino, Rodrigo;
Vives, Susana;
Guardia, Ramon;
Mercadal, Santiago;
Artola, María‐Teresa;
Cladera, Antonia;
Tormo, Mar;
Esteve, Jordi;
Bergua, Juan;
Vall‐Llovera, Ferran

Publication type:

Article